Announcements Trials
Browse Landscape

Phase

Phase 2 3Phase 3 1

Status

Terminated 2Unknown 1Completed 1

Sponsor Class

OTHER 3NIH 1

Study Type

Interventional 4

Sponsor

Cancer Type

Breast 4

Conditions

Breast Neoplasms 485Triple Negative Breast Neoplasms 28Carcinoma, Non-Small-Cell Lung 22Breast Neoplasms, Male 22Neoplasms 20Inflammatory Breast Neoplasms 20Neoplasm Metastasis 19Prostatic Neoplasms 17HER2-positive Breast Cancer 16Ovarian Neoplasms 13Lung Neoplasms 13Stomach Neoplasms 12Squamous Cell Carcinoma of Head and Neck 10Head and Neck Neoplasms 9Melanoma 8Esthesioneuroblastoma, Olfactory 8Carcinoma, Renal Cell 8Urinary Bladder Neoplasms 7Small Cell Lung Carcinoma 7Salivary Gland Neoplasms 7Pancreatic Neoplasms 7Esophageal Neoplasms 7Neutropenia 6Breast Diseases 6Sarcoma 5Carcinoma, Ovarian Epithelial 5Uterine Cervical Neoplasms 4Primary Breast Cancer 4Pathologic Complete Response 4Endometrial Neoplasms 4

Interventions

Trastuzumab 8Doxorubicin 8Exercise 6Cyclophosphamide 6Echocardiography 5Carvedilol 5Docetaxel 4Tablets 2Silymarin 2Radiotherapy 2Paclitaxel 2Magnetic Resonance Spectroscopy 2Exercise Test 2Epirubicin 2Bisoprolol 2Atorvastatin 2Anthracyclines 2sacubitril and valsartan sodium hydrate drug combination 1nicotinamide-beta-riboside 1mitoquinone 1epicatechin gallate 1empagliflozin 1dapagliflozin 1candesartan 1Watchful Waiting 1Therapeutics 1Taxes 1Tamoxifen 1Social Determinants of Health 1Secondary Prevention 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

4 trials
RecentStart dateEnrollment
Cardiotoxicity × Docetaxel × Breast × Clear all
NCT00377559 2015-10-06

MYOTAX

Catharina Ziekenhuis Eindhoven

Phase 2 Completed
70 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Cardiotoxicity

NCT00377780 2015-09-23

MYOHERTAX

Catharina Ziekenhuis Eindhoven

Phase 2 Terminated
60 enrolled
Breast

Breast Neoplasms, Neoplasm Metastasis, Cardiotoxicity

NCT01301040 2013-08-30

Early Cardiac Toxicity of Adjuvant CT in Elderly BC.

Jules Bordet Institute

Phase 2 Terminated
2 enrolled
Breast

Breast Neoplasms, Cardiotoxicity

NCT01093235 2010-03-25

Combination Chemotherapy With or Without Bevacizumab in Treating Patients With Nonmetastatic Breast Cancer

National Cancer Institute (NCI)

Phase 3 Unknown
800 enrolled
Breast

Breast Neoplasms, Postoperative Complications, Breast Neoplasms, Male, Inflammatory Breast Neoplasms, Cardiotoxicity

Data powered by HemOnc (CC BY 4.0) Colophon âš¡